StockData
Silo Pharma, Inc. logo

Silo Pharma, Inc. (SILO) stock

SILONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 2/30
$1.71+0.14 (+8.57%)

Close on Nov 17, 2026Market cap $2.72MP/E –Yield –

Silo Pharma cash

Cash and short-term investments held at the end of each period.

Silo Pharma's cash was $5.23M at Jun 30, 2026. For fiscal 2025 it was $6.86M, down 3.1% from the year before. Over ten years it grew 13.1% a year on average. The highest annual figure on record is $11.37M in fiscal 2022.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$6.86M-3.1%
FY2024Dec 31, 2024$7.08M-7.6%
FY2023Dec 31, 2023$7.67M-32.6%
FY2022Dec 31, 2022$11.37M+15.6%
FY2021Dec 31, 2021$9.84M+771.8%
FY2020Dec 31, 2020$1.13M+909.7%
FY2019Dec 31, 2019$111.75K-66.8%
FY2018Dec 31, 2018$336.68K+14.3%
FY2017Dec 31, 2017$294.59K-49.1%
FY2016Dec 31, 2016$579.21K-71.2%
FY2013Dec 31, 2013$2.01M+720552.3%
FY2012Dec 31, 2012$279-84.1%
FY2011Dec 31, 2011$1.75K-96.3%
FY2010Dec 31, 2010$47.48K–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$5.23M-16.5%
Q1 FY2026Mar 31, 2026$6.03M+10.7%
Q4 FY2025Dec 31, 2025$6.86M-3.1%
Q3 FY2025Sep 30, 2025$5.87M-26.8%
Q2 FY2025Jun 30, 2025$6.26M-17.7%
Q1 FY2025Mar 31, 2025$5.45M-28.9%
Q4 FY2024Dec 31, 2024$7.08M-19.3%
Q3 FY2024Sep 30, 2024$8.02M-19.8%
Q2 FY2024Jun 30, 2024$7.61M-33.1%
Q4 FY2023Dec 31, 2023$7.67M-37.4%
Q3 FY2023Sep 30, 2023$8.77M+0.4%
Q1 FY2023Jun 30, 2023$9.99M+10.1%
Q4 FY2022Dec 31, 2022$11.37M+15.6%
Q3 FY2022Sep 30, 2022$12.25M+19.4%
Q2 FY2022Jun 30, 2022$8.73M+110.4%
Q1 FY2022Mar 31, 2022$9.07M+95.6%
Q4 FY2021Dec 31, 2021$9.84M+771.8%
Q3 FY2021Sep 30, 2021$10.26M+523.5%
Q2 FY2021Jun 30, 2021$4.15M+116.3%
Q1 FY2021Mar 31, 2021$4.64M+50611.4%
Q4 FY2020Dec 31, 2020$1.13M+909.7%
Q3 FY2020Sep 30, 2020$1.65M+6601.9%
Q2 FY2020Jun 30, 2020$1.92M+2393.6%
Q1 FY2020Mar 31, 2020$9.14K-94.8%
Q4 FY2019Dec 31, 2019$111.75K-66.8%
Q3 FY2019Sep 30, 2019$24.56K-96.1%
Q2 FY2019Jun 30, 2019$76.97K-90.1%
Q1 FY2019Mar 31, 2019$177.35K-63.5%
Q4 FY2018Dec 31, 2018$336.68K+14.3%
Q3 FY2018Sep 30, 2018$626.12K+107.5%
Q2 FY2018Jun 30, 2018$776.21K+34.0%
Q1 FY2018Mar 31, 2018$486.27K-75.8%
Q4 FY2017Dec 31, 2017$294.59K-20.1%
Q3 FY2017Sep 30, 2017$301.69K+2888.2%
Q4 FY2016Dec 31, 2016$579.21K+207501.8%
Q4 FY2013Dec 31, 2013$2.01M+720552.3%
Q2 FY2013Jun 30, 2013$368.68K–
Q1 FY2013Mar 31, 2013$10.10K–
Q4 FY2012Dec 31, 2012$279–
Q3 FY2012Sep 30, 2012$279–

More Silo Pharma figures

See a number that looks wrong?